enerzair breezhaler (indacaterol acetate/glycopyrronium bromide/mometasone furoate) 150/50/160mcg inhalation powder hard capsule
novartis corporation (malaysia) sdn. bhd. - glycopyrronium bromide; mometasone furoate; indacaterol acetate -
atectura breezhaler (indacaterol acetate/mometasone furoate) 150/80mcg inhalation powder hard capsules
novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -
atectura breezhaler (indacaterol acetate/mometasone furoate) 150/160mcg inhalation powder hard capsules
novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -
atectura breezhaler (indacaterol acetate/mometasone furoate) 150/320mcg inhalation powder hard capsules
novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -
enerzair breezhaler 114/46/68 indacaterol/glycopyrronium/mometasone furoate 114/46/68 microgram powder for inhalation in capsule with inhaler
novartis pharmaceuticals australia pty ltd - glycopyrronium bromide, quantity: 63 microgram (equivalent: glycopyrronium, qty 50 microgram); mometasone furoate, quantity: 80 microgram; indacaterol acetate, quantity: 173 microgram (equivalent: indacaterol, qty 150 microgram) - capsule, hard - excipient ingredients: lactose monohydrate; magnesium stearate - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta2-agonist and an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
atectura breezhaler (indacaterol acetatemometasone furoate) 15080mcg inhalation powder hard capsules
novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -
atectura breezhaler (indacaterol acetatemometasone furoate) 150160mcg inhalation powder hard capsules
novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -
atectura breezhaler (indacaterol acetatemometasone furoate) 150320mcg inhalation powder hard capsules
novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -
onbrez breezhaler 150 mcg
novartis israel ltd - indacaterol as maleate - inhalation powder hard capsules - indacaterol as maleate 150 mcg - indacaterol - maintenance of bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (copd).
ultibro breezhaler 11050 mcg
novartis israel ltd - glycopyrronium as bromide; indacaterol as maleate - inhalation powder hard capsules - indacaterol as maleate 110 mcg; glycopyrronium as bromide 50 mcg - indacaterol - ultibro breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).